Explore 3 Stock Ideas & Industry Insights Download Free Report

US Equities Report

Citizens Financial Group, Inc

Sep 18, 2025

  • CFG:NYSE
  • Investment Type
    Large-cap
  • Risk Level
  • Action
  • Rec. Price (US$)

Section 1: Company Overview and Fundamentals

1.1 Company Overview:

Citizens Financial Group, Inc (NYSE: CFG) provides a broad portfolio of retail and commercial banking solutions, catering to individuals, small enterprises, middle-market clients, large corporations, and institutional customers. Its operations are structured into two primary segments: Consumer Banking and Commercial Banking.

Kalkine’s Diversified Opportunities Report covers the Company Overview, Key positives & negatives, Investment summary, Key investment metrics, Top 10 shareholding, Business updates and insights into company recent financial results, Key Risks & Outlook, Price performance and technical summary, Target Price, and Recommendation on the stock.

Stock Performance:

  • The stock shows a clear upward trend since May 2025 after bottoming near USD 34–35. Volume has remained steady, with some spikes during breakouts in June and July, confirming buying interest. Current price action is supported by healthy volumes, validating the trend
  • Both the 20-day moving average (MA20: USD 51.37) and the 50-day moving average (MA50: USD 49.42) are sloping upwards, confirming the bullish momentum. Price is currently above both the mving averages, indicating continued strength.
  • RSI (14): 64.9 – in bullish territory but not yet overbought (>70). This suggests room for further upside before overextension.

1.2 The Key Positives, Negatives, and Investment summary

1.3 Top 10 shareholders:

The top 10 shareholders together form ~ 46.46% of the total shareholding, signifying concentrated shareholding. The Vanguard Group, Inc. and Capital World Investors are the biggest shareholders, holding the maximum stake in the company at 11.90% and 8.50%, respectively.

1.4 Key Metrics:

The trend in Net Interest Income (NII) and Net Income reflects a mix of funding cost pressures, fee income volatility, and disciplined cost management. NII dipped in Q3 FY24 due to higher deposit costs but gradually recovered through asset repricing and margin expansion, reaching USD 1,437 million in Q2 FY25. Net income followed a more volatile path, declining in Q3 FY24 and Q1 FY25 on weaker capital markets activity, seasonal expense pressures, and higher provisioning, before rebounding strongly to USD 436 million in Q2 FY25. This recovery was supported by revenue growth, improved efficiency, and lower credit provisioning, highlighting the company’s ability to manage costs, optimize funding, and sustain asset quality. 

Section 2: Business Updates and Corporate Business Highlights

2.1 Recent Business Updates

2.2 Insights of Q2FY25:

Section 3: Key Risks & Outlook

Section 4: Stock Recommendation Summary:

4.1 Price Performance and Technical Summary:

Stock Performance:

  • The stock shows a clear upward trend since May 2025 after bottoming near USD 34–35. Volume has remained steady, with some spikes during breakouts in June and July, confirming buying interest. Current price action is supported by healthy volumes, validating the trend
  • Both the 20-day moving average (MA20: USD 51.37) and the 50-day moving average (MA50: USD 49.42) are sloping upwards, confirming the bullish momentum. Price is currently above both the mving averages, indicating continued strength.
  • RSI (14): 64.9 – in bullish territory but not yet overbought (>70). This suggests room for further upside before overextension.

4.2 Fundamental Valuation

Valuation Methodology: Price/Book Value per share Multiple Based Relative Valuation

Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is September 17, 2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: The report publishing date is as per the Pacific Time Zone.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

 Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

 Stop-loss: It is a level to protect against further losses in case of unfavorable movement in the stock prices.


Disclaimer-

Disclaimer This report has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine). Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.

Past performance is not a reliable indicator of future performance.